Peak XV Partners: Track Record and Key-Person Risk
Independent report content
INDEPENDENTVCFUNDANALYSIS
Peak XV Partners Multi-Stage VC (Seed → Growth) India + APAC $1.3B · Close Feb 2026 Rank #4 of 100 June 25, 2026
FUND $1.3B across India Seed + India Venture + APAC sub-funds | Close: February
20, 2026 | Type: Multi-stage VC (Seed → Growth) | Prior fund: $2.85B FIRM $10B+ AUM (13 funds, 20+ years) | Formerly Sequoia Capital India & SEA | $7B+ returned to LPs | 35, 36 portfolio IPOs | $1B+ annual returns 2024 & 2025 RECENTEXITS 5 IPOs Nov, Dec 2025: Groww, Pine Labs, Meesho, Wakefit, Capillary | Rs 300B mark-to-market + Rs 28B realised in one quarter KEYFL AG S 3 senior partners departed Feb 2026 (Agrawal 13yr, Mittal 9yr, Sharma 7yr), simultaneous with fund close. Prior: Gupta, Anand, Roychowdhary. Fund HALVED $2.85B → $1.3B. "Firm revolves around Shailendra Singh" (The Ken).
PEERSCOM PA RED General Catalyst India ($5B pledge, 2025/26) | Accel India VIII ($650M, Jan 2025) | Tiger Global India (active, reduced pace) SCORE 96/100 (Rank #4) | Track record is 10/10. Attribution is the question. Rupeia Signal Bar, Five Dimensions, Independently Assessed
GP QUALITY
7/10
TRACK RECORD
10/10
STRATEGY
8/10
ATTRIBUTION
Red
COMPETITION
Red
THE AT TRIBUTIONCRISIS
Three senior partners departed in February 2026, two weeks before the new $1.3B fund was announced. Six named departures in 24 months. Ashish Agrawal's $32M investment in Groww is now worth ~$1.8B, the most prominent single deal in recent Peak XV history. He is gone. The fund halved from $2.85B to $1.3B. Shailendra Singh is the franchise, with no named successor. At the same moment, General Catalyst pledged $5B to India. The question every LP must answer: is the Peak XV of 2026 the same as the Peak XV of 2020?
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
★ EXECUTIVE DECISION SUMMARY
THE BOTTOM
LINE Peak XV is India's largest and most powerful VC franchise by AUM, portfolio breadth and IPO exit count. $7B+ cash returned, 35 portfolio IPOs, $1B+ annual returns in 2024 and 2025 are independently verifiable facts. The Surge program, 60+ operational staff and 20-year franchise are genuinely irreplaceable. The question is not the past, it is the present: three senior partners departed Feb 2026, the fund halved to $1.3B, and there is no named successor to Singh while General Catalyst pledged $5B to India.
THE RUPEIA
NUMBER
Peak XV raised $2.85B in 2021 and $1.3B in 2026, a 54% contraction, the largest fund-size reduction in top-tier Indian VC history. Peak XV frames it as discipline; the alternative reading is that LP demand at $2.85B was not there. The same week, General Catalyst announced a $5B India commitment. One incumbent shrinking, one new entrant scaling 5x, the defining competitive signal of Indian VC in 2026.
COMFORT FIT
Peak XV = Ferrari 296 GTS. Fastest on the track (35 IPOs, $7B cash), but mid-race, three engineers just left the pit crew. General Catalyst = new Formula E team, $5B budget, AI-first, US engineering DNA. Enormous resources, zero India IPO track record.
Accel = Porsche 911. Most disciplined fund, best seed returns. A complement, not a substitute. Tiger Global = Lamborghini in maintenance mode. India pullback confirmed; allocation at a historic low. THE
COMPETITIVE
THREAT
General Catalyst's $5B is the most important competitive event in Indian VC since Sequoia India launched in 2006. GC enters with $43B global AUM, the Venture Highway acquisition, an existing Zepto/CRED/Spinny portfolio, and Hemant Taneja's personal conviction. $1.3B vs $5B means GC outguns Peak XV 3.8x in India deployment capacity for the next 5 years, an existential scale question for Peak XV's deal-access dominance.
RUPEIA INVESTMENT INTELLIGENCE | JUNE 25, 2026 | VC FUND REPORT #004 | PREPARED INDEPENDENTLY
1 FUND SNAPSHOT, PEAK XV VS THREE PEERS
DIMENSION PEAK XV
GENERAL CATALYST
INDIA ACCEL INDIA VIII TIGER GLOBAL INDIA
Fund /
commitment size $1.3B (3 sub-funds). Prior fund $2.85B. 54% contraction.
$5B pledge over 5 yrs (~$1B/yr). Not closed-end. $43B global AUM. $650M (single fund, closed Jan 2025). Same as Fund VII.
No dedicated India fund. Cross-fund allocation; est. $300, 500M/yr at 2021, 22 peak, now reduced.
Vintage /
structure
Feb 2026 close. Three sub-funds. India-primary. Closed-end (3-yr deployment). "Pledge," not closed-end.
Multi-year rolling. First India office via Venture Highway (2023). Closed-end (Jan 2025).
Delaware offshore. 2, 3yr deployment. No disclosed India vintage/structure.
Opportunistic from global Tiger funds. Stage focus Full-stack: Seed (Surge, $5M max) + Venture (Series A, C, $20, 75M) + APAC growth ($75, 100M).
AI-native primary. Fintech, healthcare, defence, industrial. Seed to growth +
company creation.
Seed → Series A. First institutional cheque. $1, 10M initial. Growth/late-stage. Series C, E. $50, 500M cheques. Now pulled back.
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
DIMENSION PEAK XV
GENERAL CATALYST
INDIA ACCEL INDIA VIII TIGER GLOBAL INDIA
India track record $7B+ returned. 35, 36 IPOs. Zomato, Meesho, Groww, Freshworks, Swiggy, Pine Labs. 20 years.
<2 years India. Zepto, CRED, Spinny, Raphe mPhibr ($100M drone). Zero India IPOs yet.
Flipkart ($1.5, 2B exit), Swiggy ($11.3B IPO). 16 years. Best seed-stage
returns.
Zomato (early), Meesho (growth). BharatPe (governance), 2021-peak write-downs.
Key people Shailendra Singh (MD, anchor), Mohit Bhatnagar, GV Ravishankar (APAC/MENA), Rajan Anandan (Surge), Rohit Agarwal, Sakshi Chopra, Abhishek Mohan (new GP).
Hemant Taneja (CEO/MD, global). Venture Highway team. No named India MD equivalent to Singh disclosed.
Shekhar Kirani, Anand Daniel, Prayank Swaroop, Subrata Mitra. All four active. Zero departures.
Scott Shleifer (co-founder). India team small, not named. Majority reduced post-2022. LP base Universities, endowments, foundations, sovereigns. Same base as historical Sequoia India.
GC global LPs (US-heavy). Backed by GC balance sheet. Not India-specific. Global Accel LPs (institutional). High quality.
Hedge-fund structure. LPs can redeem, creates India
investment volatility.
Status (Jun 2026) CLOSED. Co-invest only. NOT A TRADITIONAL FUND. $5B pledge, no formal LP
structure.
CLOSED. Co-invest only. NO ACTIVE INDIA FUND.
Portfolio management only.
2 GP QUALITY & ATTRIBUTION ANALYSIS
THE AT TRIBUTIONCRISIS , MOSTIMPOR TA NTSECTIONFORPEAKXV
Five named senior departures in 24 months (Gupta, Anand, Roychowdhary earlier; Agrawal, Mittal, Sharma in Feb 2026). Ashish Agrawal's $32M investment in Groww is now worth ~$1.8B, the most prominent single
deal in recent Peak XV history. He is gone. The attribution question is not peripheral. It is central.
TEAM
DIMENSION PEAK XV GENERAL CATALYST ACCEL INDIA
TIGER GLOBAL
INDIA
Current lead team Singh (MD, 20yr), Bhatnagar (20yr), Ravishankar (growth/APAC), Anandan (early/Surge), Rohit Agarwal, Sakshi Chopra, Abhishek Mohan (new GP).
Hemant Taneja (global CEO) + Venture Highway team. No named India MD with 10+ yr India track.
Kirani, Daniel, Swaroop, Mitra. All active. No publicly named India team. Heavily reduced post-2022.
Departures (recent) SEVERE: 6 named in 24 months. Agrawal (13yr, Groww), Mittal (9yr), Sharma (7yr) Feb 2026. TechCrunch: "internal disagreement." NONE, too new. Venture Highway integration uncertain.
NONE in 16 years. Best stability in India VC. MULTIPLE, India team reduced post- 2022. Names not disclosed.
Attribution of key deals Groww IPO ($1.8B paper from $32M): AGRAWAL, departed. Meesho: shared.
Zomato/Freshworks: early Sequoia era, unclear post-split. 5 Nov, Dec 2025 IPOs: Singh/Bhatnagar era, strong. Zepto: Accel+Nexus led, GC at growth. CRED: multi- investor. No GC-led India seed track.
Swiggy IPO ($11.3B): Daniel, active. Flipkart ($36B exit): Mitra, active. BrowserStack: Kirani, active.
Late-stage positions (Zomato, Meesho), co- investor not lead. Attribution to Tiger weak.
Succession plan NONE DISCLOSED. Singh = 20 yrs, no named successor. The Ken: "Peak XV still revolves around one." No succession question yet, Taneja is the firm. GC India needs a local MD.
Not needed, 4 founders, all active, all <55. Natural succession. N/A, India team already a skeleton crew.
Rupeia team verdict 20-year foundation irreplaceable; Surge is the best seed engine in India. But the 6- departure pattern + Feb 2026 timing is the most credibility-damaging event in Peak XV's history.
No India track to validate. Must hire an India MD and produce 2, 3 exits before the question can be answered, a 5, 7 year journey.
Best India VC team in peer group, all active, 16- yr track, zero departures, named attributable exits.
India team quality unknown; attribution as growth co-investor, not conviction lead.
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
3 TRACK RECORD VS COMPETITIVE LANDSCAPE
METRIC PEAK XV GENERAL CATALYST ACCEL INDIA TIGER GLOBAL INDIA
DPI (cash to LPs) $7B+ since inception. $1B+ annual
returns in 2024 AND 2025
(confirmed). 35, 36 IPOs. Deepest confirmed returns in Indian VC. ZERO India DPI. Entered via Venture Highway (2023). No India IPO exits yet.
Best seed DPI: Flipkart ($1.5, 2B), Swiggy ($11.3B IPO). Highest IRR per dollar in India VC.
Meaningful from Zomato; but growth entry at peak 2021, 22 produced write-downs. Net unclear.
Recent exits (2024, 26) 5 IPOs Nov, Dec 2025: Groww, Pine Labs, Meesho, Wakefit, Capillary.
Rs 300B MTM + Rs 28B realised in one quarter. None in India yet. Swiggy IPO Nov 2024 ($11.3B). BlackBuck IPO 2024.
BrowserStack private $4B+. No new India exits disclosed 2024, 26. Key concerns / write-downs Ola Electric (post-IPO decline).
Some 2021-vintage portfolio pressure. No BYJU's exposure. Not a BYJU's investor, clean. But no India track to assess patterns.
No major India write-downs. Cleanest profile. BharatPe (governance), multiple 2021-peak positions, Ola partial.
IPO pipeline (18, 24 mo) Zetwerk, Infra.market, CRED (most-watched India tech IPO candidate).
CRED, Zepto (also Accel/Nexus). No announced timelines. BrowserStack (likely next; Nasdaq potential), Urban
Company, Zetwerk.
Meesho (growth stake). Unclear whether held to IPO. DPI quality verdict GOLD STANDARD. $7B+ over 20 yrs from one firm. But 6 departures raise "whose DPI was this?", Agrawal-Groww the visible example.
N/A, value GC on the $5B pledge, not returns. GOLD STANDARD for seed. Two of the three best India VC cash
returns ever, all attributable to
active partners.
REAL BUT FRAGMENTED.
Benefits from India DPI it did not lead.
4 THE GENERAL CATALYST THREAT, A RUPEIA DEEP ANALYSIS
THISSECTIONEXISTSINNOOTHERFUNDREPORT
No Peak XV pitch deck, placement-agent note or LP diligence document will tell you what General Catalyst's $5B India commitment means for Peak XV's competitive position. Announced Feb 20, 2026, the same day as Peak XV's $1.3B close, it is the most significant competitive event in Indian VC since Sequoia India's 2006 launch.
COMPETITIVE
DIMENSION WHAT GC $5B MEANS FOR PEAK XV EVIDENCE RUPEIA ASSESSMENT
Deal competition
at Series A, B GC can write $20, 50M Series A cheques from $5B without sweating economics, vs Peak XV's $1B Venture sub-fund capacity. In contested rounds GC can price Peak XV out by 10, 20%.
GC already in Zepto, CRED, Spinny, Raphe mPhibr, deals Peak XV would typically lead.
HIGH IMPACT. Founders use GC offers to negotiate; Peak XV loses pricing power. AI-native deal competition Both explicitly position as AI-native. Taneja: "India will build the next generation of global platform companies." Singh: "sharpening focus on AI-native." Same thesis, different balance sheets.
GC: Zepto, Raphe mPhibr, PB Health. Peak XV: 80 prior AI deals claimed. Same unicorn pipeline.
MEDIUM near-term. GC wins on US connectivity; Peak XV wins where Surge sources first. LP competition GC raises from the same global base (US endowments, foundations). A fixed India allocation now splits between Peak XV and GC.
MIT, Harvard, Yale historically GC LPs, also Peak XV LPs. MEDIUM. Specialists diversify across both; new India LPs skew to GC's narrative.
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
COMPETITIVE
DIMENSION WHAT GC $5B MEANS FOR PEAK XV EVIDENCE RUPEIA ASSESSMENT
Founder recruiting / Surge GC building company creation in India, directly competes with Surge, India's most prestigious early-stage programme.
Surge: 24 cohorts since 2019, 500+ companies, Anandan leading. GC has no equivalent yet.
LOW near-term. Surge is a 7-year brand; GC can't replicate overnight. 3, 5 yr threat.
Valuation inflation Largest ($1.3B) and newest large ($1B/yr) VC
targeting the same ~300 quality startups/yr drives entry valuations up. 2021 redux risk: too much capital chasing quality. GC adds $1B/yr from 2026.
HIGH (2027, 28). Early-stage
valuations rise; Peak XV's 2026,
27 vintage faces 2021-like pressure.
5 STRATEGY TRUTH VS PORTFOLIO REALITY
DIMENSION PEAK XV GENERAL CATALYST ACCEL VIII
TIGER GLOBAL
INDIA
Stated strategy AI-native priority. Full-stack (seed→growth). India primary + APAC + MENA (Ravishankar, Dubai). Cross- border US-India.
AI-native company creation + investment. Fintech, healthcare, defence, industrials. Multi- stage.
Seed/Series A. First institutional investor. AI apps, consumer, fintech, manufacturing. India + SEA.
$650M cap. No stated India
strategy for 2026.
Legacy portfolio management. Actual deployment Prior fund: Zomato, Meesho, Groww, Pine Labs. New $1.3B early deals not yet public. Surge: 500+ companies. MENA: Huspy, Tabby, Lean.
Zepto (growth co-invest), CRED, Spinny, Raphe mPhibr. Mostly growth- stage so far.
Fund VIII: AI + Bharat/rural
additions. BrowserStack, Urban
Company active. Swiggy IPO
Nov 2024. No new scale India
investments 2025, 26.
Focus on existing
portfolio.
Strategy drift
risk
MEDIUM. Three sub-funds more disciplined than prior single $2.85B. But MENA + US are new geographies; GC's entry forces defend-or-differentiate.
HIGH but expected. No India track; first 2, 3 yrs will see sector corrections. LOWEST in group. 16 yrs, same stage/sectors. Bharat additive, not drift.
HIGH, India strategy effectively abandoned at scale. Surge, unique asset The single most important India VC advantage that cannot be replicated in <5 yrs. 24 cohorts, 500+ companies, Anandan, government goodwill. A deal- flow moat.
Plans company creation, but Surge's 7-yr head start can't be bought with $5B. No Surge equivalent, but first institutional investor in 80% of
portfolio is its own early access.
No equivalent.
6 CAPABILITY MATRIX, YES / NO / PARTIAL
CAPABILITY PEAK XV GC INDIA ACCEL VIII TIGER INDIA
35+ India portfolio IPOs YES NO PARTIAL NO $7B+ confirmed DPI to LPs (India) YES NO PARTIAL ? Active seed/early programme (Surge-equivalent) YES NO PARTIAL NO $1B+ annual India returns (2024+2025) YES NO ? NO No major partner departures in last 12 months NO YES YES NO
Fund size discipline (vs prior fund) PARTIAL ? YES NO
Full-stack India capability (seed→IPO) YES PARTIAL PARTIAL NO Global US network for India cos YES YES YES PARTIAL AI-native India investment capability YES YES PARTIAL NO India team with 10yr+ track record YES NO YES ?
Cross-border MENA/APAC capability YES PARTIAL NO NO
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
CAPABILITY PEAK XV GC INDIA ACCEL VIII TIGER INDIA
Open for new LP commitments NO PARTIAL NO NO Founder NPS / preferred-investor reputation YES PARTIAL YES NO
M AT RIXREADINGFORPEAKXV
Peak XV wins on track-record depth (35+ IPOs, $7B DPI), full-stack capability, Surge and founder- relationship quality. It loses on team stability (6 departures) and competitive scale vs GC ($1.3B vs $5B). The brand is still the strongest in India. The team is the weakest it has been in 20 years.
7 FUND-SPECIFIC RED FLAG LEDGERS
LEDGER , PEAK XV PA RTNERS
RED FLAG PUBLIC EVIDENCE SEVERITY KILL CONDITION WHAT RESOLVES IT
Triple departure simultaneous with fund close TechCrunch Feb 3, 2026: Agrawal (13yr, Groww lead), Mittal (9yr), Sharma (7yr) left simultaneously; "internal disagreement." Sharma: "starting new institution together." 17 days before the $1.3B close.
CRITICAL If the trio's new fund raises from the same LP base, the community has split its India conviction. Any close near $300M proves the alpha was team-specific.
Track their first close (H2 2026) and LP names. Historical Peak XV LPs (MIT, Yale) appearing there resolves the question against Peak XV.
$2.85B → $1.3B, contraction as demand signal TechCrunch Feb 2026: $1.3B "nearly half" the prior $2.85B (resized to $2.4B). Singh calls it discipline.
HIGH If the next fund can't hold $1.3B, contraction is secular decline. Below $800M signals LP withdrawal.
Ask what % of the $1.3B came from prior-fund LPs. Re-up <50% = real weakness; >80% = discipline narrative holds.
Shailendra Singh single-point-of- failure The Ken Feb 2026: "Peak XV still revolves around one." Leadership centred on Singh, Bhatnagar, Ravishankar. Singh 20 yrs at the firm.
HIGH Singh's departure/reduction has no named transition; LP relationships and franchise credibility concentrate in one person.
Ask directly: "If Singh steps back, who takes over LP relationships and strategy, name them." A vague answer confirms the risk.
General Catalyst $5B, pricing pressure GC commits $5B over 5 yrs ($1B/yr), announced the same day. Already in Zepto, CRED, Spinny.
HIGH If GC wins 3, 4 of the best AI/fintech Series A's in 2026, 27 by outpricing, Peak XV's Venture sub-
fund misses the cohort that matters.
Monitor Peak XV's Venture sub-
fund first 5, 6 deals. Splitting the
cohort preserves both; GC winning the majority = underperformance vs track. MENA expansion, untested geography Ravishankar Dubai-based. Three MENA seats (Huspy, Tabby, Lean).
MENA from the APAC sub-fund. MEDIUM If MENA underperforms India's track (different regulation/exits), the APAC sub-fund drags DPI.
Request APAC breakdown. MENA >25% of APAC sub-fund = concentration risk in an unproven geography.
LEDGER , GENERALC ATA LYS TINDIA
RED FLAG PUBLIC EVIDENCE SEVERITY KILL CONDITION WHAT RESOLVES IT
$5B pledge ≠ $5B fund "$5 billion over five years" is a corporate pledge, not a closed-end
fund with capital calls, J-curves
and LP governance. HIGH If GC's global LPs face redemption pressure (as Tiger did 2022, 23), the India "commitment" can be quietly reduced. LPs cannot enforce deployment.
Verify a dedicated SEBI-registered AIF or formal structure. Ask: is the $5B a closed-end India fund or a directional target from the global
fund?
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
RED FLAG PUBLIC EVIDENCE SEVERITY KILL CONDITION WHAT RESOLVES IT
No India IPO
track record
Entered via Venture Highway (2023). Zepto, CRED, Spinny, Raphe mPhibr. Zero India IPOs. India IPO process differs entirely from US.
HIGH If GC makes 15, 20 investments 2026, 28 and produces no India IPO by 2030, the $5B becomes a capital trap. Monitor whether GC hires India capital-markets/IPO infrastructure.
Reliance on global banks alone leaves the local-exit gap open. Venture Highway integration unclear Acquired 2023. No Venture Highway partner prominent as lead in GC India deal press.
MEDIUM If the acquisition was talent/network without functional integration, GC has ambition but no local deal-leading team.
Ask which former VH partners are active and which current deals they led. No clear answer = India team is Taneja's personal network.
LEDGER , ACCELINDIAVIII & TIGERG LO BALINDIA
RED FLAG PUBLIC EVIDENCE SEVERITY KILL CONDITION WHAT RESOLVES IT
Accel, no major
fund-specific red
flags Zero partner departures (16yr). $650M consistent size. First institutional investor in 80%. Flipkart + Swiggy confirm repeatability.
LOW Only material risk is macro (India IPO market cooling), not fund- specific. Included to show what a clean profile looks like next to Peak XV's situation. Full analysis in VC Report #003.
Tiger, significant India pullback Deployment dramatically reduced post-2022. Multiple 2021-peak write- downs. India team reduced.
HIGH Not an active LP entry point.
Portfolio companies face
governance risk if Tiger reduces
board engagement.
Portfolio companies: verify
whether Tiger keeps its board seat or has gone passive. Tiger, hedge-
fund redemption
risk
Hedge-fund structure for some capital; 2022, 23 redemptions forced global position adjustments incl. India.
CRITICAL Another global risk-off event could force India liquidation in secondary at a discount, suppressing unicorn
valuations.
Structural risk, monitor Tiger global redemption headlines as a leading indicator of India capital withdrawal.
8 INVESTOR CLASS ANALYSIS
For Individual Investors / HNIs Peak XV, Accel and Tiger are inaccessible to individuals directly, and General Catalyst is not structured to accept individual LP commitments. The practical options: (1) a fund-of-funds holding Peak XV and/or Accel positions, accessible at Rs 1, 5 Cr via SEBI AIF Category I; ask specifically whether the FoF holds current- vintage or legacy positions, since a 2021-vintage Peak XV position is a different asset than a 2026-vintage one. (2) Direct co-invest via the Surge network, Surge graduates raising Series A occasionally offer co-invest slots to trusted HNI networks. (3) Blume Fund V and 3one4 Fund IV (VC Report #003) for direct AIF access at seed, the feeder into the eventual Peak XV pipeline.
For Family Offices (Rs 200+ Cr) Peak XV co-invest is the target for any family office with Rs 200+ Cr and existing India VC LP relationships. The Feb 2026 departures create a window: portfolio companies once managed by Agrawal, Mittal or Sharma are in board transition, and family offices that add value beyond capital can co-invest at more reasonable terms. Co-investing in a Series B fintech/consumer company alongside Peak XV provides institutional
diligence at no cost, governance through the Peak XV board seat, and the Peak XV brand for the company's
future rounds. GC India is not yet a co-invest vehicle in the traditional sense, monitor whether it creates a dedicated India AIF (likely 2026, 27). For family offices with no existing relationship, the path to Peak XV is
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
via Surge-company direct investments → track record with founders → introduction → co-invest invitation, an 18, 24 month build. Start now. For Institutions (CVCs, Pension Funds, Endowments) Peak XV is the institutional India VC anchor, if and only if the attribution question resolves satisfactorily.
The $7B DPI, 35 IPOs and $1B+ annual returns make it the most proven India VC track available, but the allocation committee must answer one question: "Are we investing in Shailendra Singh, or in Peak XV Partners?" If Singh: the current roster (Singh, Bhatnagar, Ravishankar, Anandan) is still strong. If the institution: it survived the departures and the Sequoia split, and the $7B DPI proves resilience. Either answer leads to the same commitment via a different diligence path. GC India is the second allocation, but only for a 7, 10 year horizon with tolerance for zero India DPI in years 1, 4; wait for 2, 3 India exits before scale. For pension funds building first India alternatives exposure, start with Accel (proven, disciplined) and add Peak XV in the next cycle.
9 COMFORT FIT, THE DECISION PAGE
IF YOU WANT… BEST FIT WHY CAUTION
Deepest India VC track record in history PEAK XV 35, 36 IPOs. $7B+ returned. $1B+ annual
returns 2024+2025. Nothing comes close.
3 senior departures Feb 2026. Singh single- point-of-failure. $2.85B → $1.3B contraction. AI-native India with $5B deployment capacity GC INDIA $1B/yr. Taneja's personal conviction. GC global AI network.
No India track. $5B is a pledge. Zero India IPOs. India team not publicly identified. Best confirmed seed-stage cash returns ACCEL VIII Flipkart + Swiggy from seed. Zero departures.
Closed Jan 2025. Co-invest only. Requires relationship. Full-stack from seed to growth in one family PEAK XV Surge + Venture sub-fund + APAC. No other India fund covers this breadth.
Multiple sub-funds = complexity; attribution hard to track. MENA new. India AI seed access (pre- Series A)
PEAK XV
SURGE
500+ companies across 24 cohorts. Best India seed-AI deal flow. Access requires Peak XV LP relationship or founder network.
Newly open India LP entry at $1B+ scale GC INDIA Only $1B+ India commitment still theoretically accessible.
Not a traditional fund. No formal LP protection. Allocation could be reduced. Lowest single-GP concentration risk ACCEL VIII Four equal founding partners, all active.
No one person is the franchise. Closed. Next window: Fund IX 2027, 28. Co-invest with MENA + India + SEA exposure PEAK XV Ravishankar leads MENA + India + SEA from one firm. Unique cross-geography.
MENA unproven for Peak XV. Three geographies = stretch.
10 RUPEIA FINAL INDEPENDENT VIEW
Peak XV is the most complex evaluation in this series. The track record (35 IPOs, $7B DPI, $1B+ annual
returns) is better than any other India VC firm by a wide margin. The current team situation (6 departures in
24 months, Singh as functional sole anchor, no named successor) is the weakest Peak XV has been in 20 years. Both facts coexist. The track record justifies Peak XV in the portfolio; the team situation requires a direct conversation with Singh, not IR, not a deck, before committing. Ask him: "Who is your #2? Who runs
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
Peak XV India if you step back in 3 years?" His answer tells you whether the franchise is durable or already in managed decline. 1 Peak XV Partners, Best track, caveat team Co-invest only (closed Feb 2026). Attribution question central.
RUPEIA CALL: ENGAGE. RESOLVE THE ATTRIBUTION QUESTION DIRECTLY WITH SINGH. IF SATISFIED, PEAK XV CO-
INVEST IS THE HIGHEST-QUALITY INDIA VC EXPOSURE AVAILABLE. IF NOT, WAIT FOR FUND XI AND TRACK THE
DEPARTED TRIO'S FIRST CLOSE FIRST.
2 Accel India VIII, Best seed returns, build relationship Co-invest only (closed Jan 2025). Cleanest profile in Indian VC.
RUPEIA CALL: BUILD RELATIONSHIP FOR FUND IX (LIKELY 2027, 28). SEE VC REPORT #003 FOR FULL ANALYSIS.
3 General Catalyst India, Highest potential, zero India proof A pledge, not a traditional fund.
RUPEIA CALL: MONITOR FOR 2 YEARS. INVEST IN THE RELATIONSHIP NOW, NOT THE CAPITAL. COMMIT ONLY AFTER
GC PRODUCES ITS FIRST INDIA EXIT.
4 Tiger Global India, Legacy portfolio, not active No active India fund raising.
RUPEIA CALL: DO NOT SEEK NEW INDIA EXPOSURE VIA TIGER. MANAGE EXISTING POSITIONS ONLY, TIGER IS
MANAGING DOWN, NOT UP.
THERUPEIANUMBERFORPEAKXV
Prior fund: $2.85B. Current fund: $1.3B. A 54% contraction. At the exact same moment (Feb 20, 2026), General Catalyst announced a $5B India commitment. One India VC legend shrinking by half; one US VC giant expanding by 5x, in the same week. The Rupeia Number is not one number, it is the ratio: $1.3B vs $5B. The competitive landscape of India VC shifted more in one week than in the prior five years.
RUPEIAVERDICT
The track record is gold-standard and justifies Peak XV in any India VC portfolio. The team situation is the weakest in 20 years and demands a direct Singh conversation before committing. Engage Peak XV with the attribution question resolved; build the Accel relationship for Fund IX; monitor GC India for 2 years; avoid Tiger for new India exposure.
RUPEIA PEAK XV VS PEERS INDEPENDENT VC FUND ANALYSIS
11 SOURCE LOG
REF SOURCE DATE KEY DATA CONFIDENCE
[1] TechCrunch (Manish Singh) Feb 20, $1.3B raise; $7B+ returned; 35 IPOs; departures context; GC competition HIGH [2] TechCrunch (Jagmeet Singh) Feb 3, 2026 Agrawal, Mittal, Sharma departures; Groww $32M→$1.8B; Abhishek Mohan GP promotion HIGH [3] The Ken Feb 2026 "Peak XV still revolves around one." Groww power equations HIGH [4] TechBuzz.ai / Entrepreneur India Feb 20, GC $5B India pledge; $43B global AUM; Zepto, CRED, Spinny; Raphe mPhibr $100M HIGH [5] MLQ.ai / VCWire Feb 2026 $1.3B vs $2.85B; MENA expansion (Ravishankar Dubai); 5 of 7 MDs >10 yrs MEDIUM [6] BW Disrupt Feb 21, Venture Highway acquisition 2023; company creation; GC India sectors HIGH [7] Accel India / TechCrunch Jan 2025 Accel Fund VIII $650M; size cap; Swiggy + Flipkart HIGH The Standard This report compares Peak XV Partners, General Catalyst India, Accel India VIII and Tiger Global India, from public information only, without access to any fund's data room. The fund-specific red-flag ledgers name what no pitch deck will. The attribution crisis at Peak XV, the zero-track-record risk at GC India, and the $1.3B vs $5B competitive ratio are this report's three findings, they appear together in no other published document on Indian VC.
DISCLAIMER
This document is published strictly for informational, educational, and academic record-keeping purposes only. The publisher of this document is not a SEBI Registered Investment Adviser (RIA), nor a SEBI Registered Research Analyst (RA). This report does not constitute personal investment advice, an independent research report, a financial recommendation, or an offer or solicitation to buy, sell, or subscribe to any securities. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
